Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-29

Clinical Trial Update: Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating diuretics versus afterload reduction for managing HeartLogic alerts in heart failure patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Heart Center Research, LLC | Conditions: Heart Failure, Congestive | Phase 4 | Status: RECRUITING